Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Assaf-Harofeh Medical Center.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Apos Medical and Sports Technology Ltd.
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT01266382
First received: December 22, 2010
Last updated: December 23, 2010
Last verified: July 2009

December 22, 2010
December 23, 2010
Not Provided
Not Provided
  • Spatio-temporal Gait parameters [ Designated as safety issue: No ]
  • WOMAC [ Designated as safety issue: No ]
  • SF-36 [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01266382 on ClinicalTrials.gov Archive Site
  • FAOS questionnaire
  • Oswestry questionnaire
  • Clinical measurements
Same as current
Not Provided
Not Provided
 
The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders
Not Provided

The purpose of the study is to examine the effect of a new biomechanical device and treatment methodology (AposTherapy) on gait patterns, pain, function and quality of life of patients with musculoskeletal and neurological disorders. Based on previous reports the investigators hypothesis that this therapy will have a positive effect on these measurements.

Not Provided
Interventional
Not Provided
Primary Purpose: Treatment
  • Osteoarthritis
  • Spinal Diseases
  • Ligament Rupture
  • Lower Extremity Fracture
  • Neurological Disorders
Device: AposTherapy
a biomechanical device including 2 hemispheric biomechanical elements attached to a platform in a form of a shoe. the biomechanical device is calibrated to each patient by a physiotherapist specialized with the treatment methodology. patient are instructed to walk indoor with the device. time of exercise is gradually increase
Not Provided
Segal G, Bar-Ziv Y, Velkes S, Benkovich V, Stanger G, Debbi EM, Debi R, Mor A, Elbaz A. A non-invasive biomechanical device and treatment for patients following total hip arthroplasty: results of a 6-month pilot investigation. J Orthop Surg Res. 2013 May 21;8:13. doi: 10.1186/1749-799X-8-13.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Primary osteoarthritis
  • Lower limb joint replacement
  • Lower limbs fractures
  • Spinal disorders including LBP w/wo refered symptoms, radiculopathy, spinal stenosis
  • ligaments tear
  • Meniscal tears

Exclusion Criteria:

  • lack of balance (3 falls in the last year)
  • incapable to complete a questionnaire •>age 85
Both
18 Years to 85 Years
Yes
Contact: Ganit Segal, MA ganitm@apos.co.il
Israel
 
NCT01266382
93/09
No
Not Provided
Assaf-Harofeh Medical Center
Apos Medical and Sports Technology Ltd.
Not Provided
Assaf-Harofeh Medical Center
July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP